Article metrics

Original research
Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study

 

Online download statistics by month:

Online download statistics by month: October 2020 to September 2021

AbstractFullPdf
Oct 2020422415159
Nov 2020278271109
Dec 202012312333
Jan 202110910548
Feb 2021676718
Mar 2021787624
Apr 2021979640
May 2021929152
Jun 2021758045
Jul 2021595928
Aug 2021434315
Sep 2021273216
Total14701458587